Delivery Order SPE2DX22D0059-SPE2D824F0DCP

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $10K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division provides medical supplies and pharmaceutical products to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $15,771.39, is a firm fixed price contract with a period of performance through August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, that...
This federal contract award is for a delivery order with a ceiling value of $18,409.50, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at up to $1,418.40, is for the delivery of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the U.S. federal government, holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of various pharmaceutical products and medical supplies to support the U.S. government's medical requirements. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,345.86 and a completion date of August 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen will provide a comprehensive range of medications, including specialty, brand name, generic,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $16,442.64 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract is not set-aside and has a ceiling value of $999,999,999 through December 2025. Amerisourcebergen,...
This federal contract award, valued at $10,447.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. Amerisourcebergen, a major pharmaceutical distributor, will provide a variety of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities and healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $11,668.34, and has an ultimate completion date of October...
  • SPE2DX22D0059
    Indefinite Delivery Contract
  • SPE2DX22D0059-SPE2D824F0DCP
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical and medical supply distributor in the United States. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $10,137.49. It is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is valid through December 2025. The contract is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation and was awarded on August 12, 2024, with an ultimate completion date of August 13, 2024.

Generated 11/11/24, 9:28 AM